Do Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Require Ceftaroline Dosage Adjustments? Ceftaroline PopPK Model and Dosage Simulations with the Probability of Target Attainment Analysis Based on Retrospective Data

<b>Objectives</b>: We aimed to develop a population pharmacokinetic (PopPK) model and evaluate dosing regimens for different renal clearances and continuous renal replacement therapy (CRRT) settings. <b>Methods</b>: Data were collected from four studies in intensive care unit...

Full description

Saved in:
Bibliographic Details
Main Authors: Arkadiusz Adamiszak, Krzysztof Pietrzkiewicz, Alicja Bartkowska-Śniatkowska, Piotr Smuszkiewicz, Krzysztof Kusza, Edmund Grześkowiak, Agnieszka Bienert
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/14/4/347
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850143571351437312
author Arkadiusz Adamiszak
Krzysztof Pietrzkiewicz
Alicja Bartkowska-Śniatkowska
Piotr Smuszkiewicz
Krzysztof Kusza
Edmund Grześkowiak
Agnieszka Bienert
author_facet Arkadiusz Adamiszak
Krzysztof Pietrzkiewicz
Alicja Bartkowska-Śniatkowska
Piotr Smuszkiewicz
Krzysztof Kusza
Edmund Grześkowiak
Agnieszka Bienert
author_sort Arkadiusz Adamiszak
collection DOAJ
description <b>Objectives</b>: We aimed to develop a population pharmacokinetic (PopPK) model and evaluate dosing regimens for different renal clearances and continuous renal replacement therapy (CRRT) settings. <b>Methods</b>: Data were collected from four studies in intensive care unit (ICU) adult patients receiving 400–600 mg of ceftaroline every 8–12 h in a one-hour infusion. The PopPK model was developed according to non-linear mixed effects modeling implemented in Monolix 2024R1. To investigate dosing recommendations, Monte Carlo simulations and probability of target attainment (PTA) analysis were performed in Simulx 2024R1. <b>Results</b>: We collected 296 plasma concentrations from 29 non-CRRT patients and 24 pre-filter (systemic), 23 post-filter, and 23 effluent concentrations from four CRRT patients using WebPlotDigitizer (Version 4.7). A five-compartment model, with the first-order elimination from the central compartment and additional elimination with the effluent during CRRT, best described the ceftaroline concentrations. Creatinine clearance (<i>Cl<sub>Cr</sub></i>) was identified as a covariate on the clearance of elimination (<i>Cl</i>) and CRRT modality on the central and peripheral compartments’ volumes and intercompartmental clearance. The results of dosage simulations for different CRRT modalities and <i>Cl<sub>Cr</sub></i>, <i>S. pneumoniae</i> (MIC = 0.25 mg/L) and methicillin-resistant <i>S. aureus</i> (MRSA) (MIC = 1 mg/L) infections, and assumed 100%ƒT<sub>>MIC</sub> target, revealed that registered ceftaroline dosages are sufficient to achieve assumed PTA, except MRSA infection in patients with augmented renal clearance (ARC). <b>Conclusions</b>: Our successfully developed model allows flexible PK simulations of ceftaroline, including real-time changes in settings and even temporary or permanent cessation of CRRT. However, the results of our study warrant clinical validation and should be used with caution primarily due to the limited CRRT patient number included in the analysis.
format Article
id doaj-art-45a402dd8ef941aa9f95a99ed4afc79a
institution OA Journals
issn 2079-6382
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj-art-45a402dd8ef941aa9f95a99ed4afc79a2025-08-20T02:28:40ZengMDPI AGAntibiotics2079-63822025-03-0114434710.3390/antibiotics14040347Do Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Require Ceftaroline Dosage Adjustments? Ceftaroline PopPK Model and Dosage Simulations with the Probability of Target Attainment Analysis Based on Retrospective DataArkadiusz Adamiszak0Krzysztof Pietrzkiewicz1Alicja Bartkowska-Śniatkowska2Piotr Smuszkiewicz3Krzysztof Kusza4Edmund Grześkowiak5Agnieszka Bienert6Department of Pharmacology, Poznan University of Medical Sciences, 60-806 Poznan, PolandDepartment of Paediatric Anaesthesiology and Intensive Therapy, Poznan University of Medical Sciences, 60-572 Poznan, PolandDepartment of Paediatric Anaesthesiology and Intensive Therapy, Poznan University of Medical Sciences, 60-572 Poznan, PolandDepartment of Anesthesiology, Intensive Therapy and Pain Management, Poznan University of Medical Sciences, 60-352 Poznan, PolandDepartment of Anesthesiology, Intensive Therapy and Pain Management, Poznan University of Medical Sciences, 60-352 Poznan, PolandDepartment of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, 60-806 Poznan, PolandDepartment of Pharmacology, Poznan University of Medical Sciences, 60-806 Poznan, Poland<b>Objectives</b>: We aimed to develop a population pharmacokinetic (PopPK) model and evaluate dosing regimens for different renal clearances and continuous renal replacement therapy (CRRT) settings. <b>Methods</b>: Data were collected from four studies in intensive care unit (ICU) adult patients receiving 400–600 mg of ceftaroline every 8–12 h in a one-hour infusion. The PopPK model was developed according to non-linear mixed effects modeling implemented in Monolix 2024R1. To investigate dosing recommendations, Monte Carlo simulations and probability of target attainment (PTA) analysis were performed in Simulx 2024R1. <b>Results</b>: We collected 296 plasma concentrations from 29 non-CRRT patients and 24 pre-filter (systemic), 23 post-filter, and 23 effluent concentrations from four CRRT patients using WebPlotDigitizer (Version 4.7). A five-compartment model, with the first-order elimination from the central compartment and additional elimination with the effluent during CRRT, best described the ceftaroline concentrations. Creatinine clearance (<i>Cl<sub>Cr</sub></i>) was identified as a covariate on the clearance of elimination (<i>Cl</i>) and CRRT modality on the central and peripheral compartments’ volumes and intercompartmental clearance. The results of dosage simulations for different CRRT modalities and <i>Cl<sub>Cr</sub></i>, <i>S. pneumoniae</i> (MIC = 0.25 mg/L) and methicillin-resistant <i>S. aureus</i> (MRSA) (MIC = 1 mg/L) infections, and assumed 100%ƒT<sub>>MIC</sub> target, revealed that registered ceftaroline dosages are sufficient to achieve assumed PTA, except MRSA infection in patients with augmented renal clearance (ARC). <b>Conclusions</b>: Our successfully developed model allows flexible PK simulations of ceftaroline, including real-time changes in settings and even temporary or permanent cessation of CRRT. However, the results of our study warrant clinical validation and should be used with caution primarily due to the limited CRRT patient number included in the analysis.https://www.mdpi.com/2079-6382/14/4/347ceftarolinecontinuous renal replacement therapypopulation pharmacokineticsMonte Carlo simulationsprobability of target attainmentintensive care unit
spellingShingle Arkadiusz Adamiszak
Krzysztof Pietrzkiewicz
Alicja Bartkowska-Śniatkowska
Piotr Smuszkiewicz
Krzysztof Kusza
Edmund Grześkowiak
Agnieszka Bienert
Do Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Require Ceftaroline Dosage Adjustments? Ceftaroline PopPK Model and Dosage Simulations with the Probability of Target Attainment Analysis Based on Retrospective Data
Antibiotics
ceftaroline
continuous renal replacement therapy
population pharmacokinetics
Monte Carlo simulations
probability of target attainment
intensive care unit
title Do Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Require Ceftaroline Dosage Adjustments? Ceftaroline PopPK Model and Dosage Simulations with the Probability of Target Attainment Analysis Based on Retrospective Data
title_full Do Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Require Ceftaroline Dosage Adjustments? Ceftaroline PopPK Model and Dosage Simulations with the Probability of Target Attainment Analysis Based on Retrospective Data
title_fullStr Do Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Require Ceftaroline Dosage Adjustments? Ceftaroline PopPK Model and Dosage Simulations with the Probability of Target Attainment Analysis Based on Retrospective Data
title_full_unstemmed Do Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Require Ceftaroline Dosage Adjustments? Ceftaroline PopPK Model and Dosage Simulations with the Probability of Target Attainment Analysis Based on Retrospective Data
title_short Do Critically Ill Patients Undergoing Continuous Renal Replacement Therapy Require Ceftaroline Dosage Adjustments? Ceftaroline PopPK Model and Dosage Simulations with the Probability of Target Attainment Analysis Based on Retrospective Data
title_sort do critically ill patients undergoing continuous renal replacement therapy require ceftaroline dosage adjustments ceftaroline poppk model and dosage simulations with the probability of target attainment analysis based on retrospective data
topic ceftaroline
continuous renal replacement therapy
population pharmacokinetics
Monte Carlo simulations
probability of target attainment
intensive care unit
url https://www.mdpi.com/2079-6382/14/4/347
work_keys_str_mv AT arkadiuszadamiszak docriticallyillpatientsundergoingcontinuousrenalreplacementtherapyrequireceftarolinedosageadjustmentsceftarolinepoppkmodelanddosagesimulationswiththeprobabilityoftargetattainmentanalysisbasedonretrospectivedata
AT krzysztofpietrzkiewicz docriticallyillpatientsundergoingcontinuousrenalreplacementtherapyrequireceftarolinedosageadjustmentsceftarolinepoppkmodelanddosagesimulationswiththeprobabilityoftargetattainmentanalysisbasedonretrospectivedata
AT alicjabartkowskasniatkowska docriticallyillpatientsundergoingcontinuousrenalreplacementtherapyrequireceftarolinedosageadjustmentsceftarolinepoppkmodelanddosagesimulationswiththeprobabilityoftargetattainmentanalysisbasedonretrospectivedata
AT piotrsmuszkiewicz docriticallyillpatientsundergoingcontinuousrenalreplacementtherapyrequireceftarolinedosageadjustmentsceftarolinepoppkmodelanddosagesimulationswiththeprobabilityoftargetattainmentanalysisbasedonretrospectivedata
AT krzysztofkusza docriticallyillpatientsundergoingcontinuousrenalreplacementtherapyrequireceftarolinedosageadjustmentsceftarolinepoppkmodelanddosagesimulationswiththeprobabilityoftargetattainmentanalysisbasedonretrospectivedata
AT edmundgrzeskowiak docriticallyillpatientsundergoingcontinuousrenalreplacementtherapyrequireceftarolinedosageadjustmentsceftarolinepoppkmodelanddosagesimulationswiththeprobabilityoftargetattainmentanalysisbasedonretrospectivedata
AT agnieszkabienert docriticallyillpatientsundergoingcontinuousrenalreplacementtherapyrequireceftarolinedosageadjustmentsceftarolinepoppkmodelanddosagesimulationswiththeprobabilityoftargetattainmentanalysisbasedonretrospectivedata